R von Moos
Endocrine symptom assessment in women with breast cancer: what a simple "yes" means
Ribi K, Bernhard J, Rufibach K, Thürlimann B, von Moos R, Ruhstaller T, Glaus A, Böhme C. Endocrine symptom assessment in women with breast cancer: what a simple "yes" means. JSCC 2007; 15:1349-56.
01.12.2007Endocrine symptom assessment in women with breast cancer: what a simple "yes" means
01.12.2007JSCC 2007; 15:1349-56
Ribi K, Bernhard J, Rufibach K, Thürlimann Beat, von Moos R, Ruhstaller Thomas, Glaus A, Böhme C
Feasibility of using cetuximab and bevacizumab in a patient with colorectal cancer and terminal renal failure
Inauen R, Cathomas R, Boehm T, Pestalozzi B, Gillessen Sommer S, von Moos R. Feasibility of using cetuximab and bevacizumab in a patient with colorectal cancer and terminal renal failure. Oncology 2007; 72:209-10.
01.01.2007Feasibility of using cetuximab and bevacizumab in a patient with colorectal cancer and terminal renal failure
01.01.2007Oncology 2007; 72:209-10
Inauen Roman, Cathomas R, Boehm T, Pestalozzi B C, Gillessen Sommer Silke, von Moos R
Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment
Glaus A, Böhme C, Thürlimann B, Ruhstaller T, Hsu Schmitz S, Morant R, Senn H, von Moos R. Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment. Ann Oncol 2006; 17:801-6.
01.05.2006Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment
01.05.2006Ann Oncol 2006; 17:801-6
Glaus A, Böhme Christel, Thürlimann Beat, Ruhstaller Thomas, Hsu Schmitz S F, Morant R, Senn H J, von Moos R
Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer
Fürstenberger G, von Moos R, Lucas R, Thürlimann B, Senn H, Hamacher J, Boneberg E. Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer. BJC 2006; 94:524-31.
27.02.2006Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer
27.02.2006BJC 2006; 94:524-31
Fürstenberger G, von Moos R, Lucas R, Thürlimann Beat, Senn H-J, Hamacher J, Boneberg E-M
Weekly paclitaxel (Taxol) with or without trastuzumab (Herceptin) in advanced breast cancer: a community-based observation study
von Moos R, Thürlimann B. Weekly paclitaxel (Taxol) with or without trastuzumab (Herceptin) in advanced breast cancer: a community-based observation study. Onkologie 2003; 26:128-32.
01.04.2003Weekly paclitaxel (Taxol) with or without trastuzumab (Herceptin) in advanced breast cancer: a community-based observation study
01.04.2003Onkologie 2003; 26:128-32
von Moos R, Thürlimann Beat